Literature DB >> 16959662

Restoration of satisfying sex for a castrated cancer patient with complete impotence: a case study.

Karen M Warkentin1, Ross E Gray, Richard J Wassersug.   

Abstract

We present a first-hand account of a fully impotent, testosterone-suppressed prostate cancer patient who has satisfying, multiorgasmic sex using a strap-on dildo. We use his narrative to examine dildos as an alternative to erectile dysfunction treatments for men, such as this patient, who find selective inhibitors of PDE-5 ineffective and surgical intervention unacceptable. We explore what conditions allowed this man to progress from suspicious distrust of the dildo to full acceptance. In terms of making a dildo acceptable to other patients, we contrast offering it to them as a penile prosthesis in a formal medical setting versus treating it as a toy in fantasy sex play. Last, we present a neurobiological hypothesis involving sensory integration to help explain why sex with the strap-on dildo can be satisfying to a male.

Entities:  

Mesh:

Year:  2006        PMID: 16959662     DOI: 10.1080/00926230600835346

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  11 in total

1.  Impact of androgen deprivation therapy on sexual function: a response.

Authors:  Erik Wibowo; Richard Wassersug; Karen Warkentin; Lauren Walker; John Robinson; Lori Brotto; Thomas Johnson
Journal:  Asian J Androl       Date:  2012-07-16       Impact factor: 3.285

Review 2.  Psychosocial perspectives on sexual recovery after prostate cancer treatment.

Authors:  Lauren M Walker; Richard J Wassersug; John W Robinson
Journal:  Nat Rev Urol       Date:  2015-03-10       Impact factor: 14.432

Review 3.  Eroticization as a factor influencing erectile dysfunction treatment effectiveness.

Authors:  K C Kukula; R A Jackowich; R J Wassersug
Journal:  Int J Impot Res       Date:  2013-07-04       Impact factor: 2.896

Review 4.  Canadian Men's Self-Management of Chronic Diseases: A Literature Analysis of Strategies for Dealing With Risks and Promoting Wellness.

Authors:  Margareth S Zanchetta; Christine Maheu; Olesya Kolisnyk; Mohamed Mohamed; Sepali Guruge; Diana Kinslikh; Joneet J Christopher; Melissa Stevenson; CaroLine SanJose; Terry Sizto; Aaron Byam
Journal:  Am J Mens Health       Date:  2015-03-23

Review 5.  Coping with sexual concerns after cancer: the use of flexible coping.

Authors:  Jennifer Barsky Reese; Francis J Keefe; Tamara J Somers; Amy P Abernethy
Journal:  Support Care Cancer       Date:  2010-02-18       Impact factor: 3.603

Review 6.  Clinical use and implications of sexual devices and sexually explicit media.

Authors:  Marieke Dewitte; Yacov Reisman
Journal:  Nat Rev Urol       Date:  2021-05-04       Impact factor: 14.432

7.  Flexibility in Men's Sexual Practices in Response to Iatrogenic Erectile Dysfunction after Prostate Cancer Treatment.

Authors:  Gary W Dowsett; Anthony Lyons; Duane Duncan; Richard J Wassersug
Journal:  Sex Med       Date:  2014-08       Impact factor: 2.491

Review 8.  Non-pharmacological and non-surgical strategies to promote sexual recovery for men with erectile dysfunction.

Authors:  Richard Wassersug; Erik Wibowo
Journal:  Transl Androl Urol       Date:  2017-11

Review 9.  Interventions for sexual dysfunction following treatments for cancer in women.

Authors:  Bridget Candy; Louise Jones; Victoria Vickerstaff; Adrian Tookman; Michael King
Journal:  Cochrane Database Syst Rev       Date:  2016-02-02

10.  TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial.

Authors:  D Wittmann; A Mehta; L Northouse; R Dunn; T Braun; A Duby; L An; L Arab; R Bangs; S Bober; J Brandon; M Coward; M Dunn; M Galbraith; M Garcia; J Giblin; M Glode; B Koontz; A Lowe; S Mitchell; J Mulhall; C Nelson; K Paich; C Saigal; T Skolarus; J Stanford; T Walsh; C E Pollack
Journal:  BMC Cancer       Date:  2017-10-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.